{
  "report_rows": [
    {
      "kpi": "Comparable EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.96 vs. cons $0.93",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$13.1B vs. cons $13.2B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic Revenue Growth",
      "prediction": "MISS",
      "answer": "pred ~3.0% vs. cons 3.5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 Organic Revenue Growth Guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~4.5% vs. cons 4.4% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 Comparable EPS Growth Guidance",
      "prediction": "BETTER",
      "answer": "guide ~8.5% vs. cons 8.0% (FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "H2 Fairlife/Supply Disruption EPS Impact Commentary",
      "prediction": "LOWER",
      "answer": "guide ~-100bps vs. cons 0bps (H2 2026 EPS headwind)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 0.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.1,
  "day5_path": "FADE",
  "day5_rationale": "EPS beat driven largely by FX tailwind and tax rate, not underlying volume/organic acceleration; organic growth miss vs. consensus (concentrate lag already flagged) and explicit H2 Fairlife/A&D headwinds give sell-side room to trim H2/FY27 estimates even after a modest EPS beat. With KO near all-time highs and priced for perfection, any incremental caution on margin/tax overhang (IRS dispute) or CCBA timing likely causes analysts to temper out-period numbers over the following days, fading the initial pop.",
  "day5_confidence": "MEDIUM"
}